IART: integralife.com Expected earnings per share growth for next year
Integra LifeSciences dominates regenerative medicine, ensuring stable demand through established standards of care. The trend of the company's forward EPS estimates on the GURU.Markets chart visualizes these expectations, where 1.50 determines this parameter level. The business demonstrates high macroeconomic resilience regardless of the cycle, while deep brand penetration in clinics minimizes the risk of market share loss.
Analytical breakdowns for integralife.com (IART)
- share price and consensus valuation forecast:
- market capitalization information:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Capital Integra LifeSciences|IART - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Integra LifeSciences Holdings Corporation|IART - Company Total Debt Obligations|Debts to Book Capitalization Integra LifeSciences|IART - Company Long-Term Liabilities|Company Short-Term Debts Integra LifeSciences|Quick Liquidity integralife.com
- net income and valuation ratios data:
IART - Company Net Income|Future Profit Integra LifeSciences|IART - Company Value to Net Income|Forward P/E Multiple Integra LifeSciences|IART - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Integra LifeSciences|IART - Operating profit before depreciation charges|Net earnings per share for the last 12 months Integra LifeSciences|IART - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth integralife.com|IART - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Integra LifeSciences
Initial company analysis:Integra, IART
Surgeons' brand loyalty to Integra LifeSciences (IART) allows the company to recover its market position through production modernization, which directly impacts the consensus forecast for net profit growth rates. Analyzing the prospects for EPS changes next year, the investor assesses the expected profit dynamics for the coming period, where excessive optimism in the curve may signal an overvaluation of the asset and the risk of capital freeze.
Analysis of competing companies
BSX (Boston Scientific Inc) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year EW (Edwards Lifesciences Inc.)|Expected earnings per share growth for next year RMD (ResMed Inc.)|PODD (insulet.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Zimmer Biomet Holdings Inc ZBH|COO - Expected earnings per share growth for next year|Align Technology Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year NuVasive|TMDX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ATEC|AORT (Artivion) - Earnings growth forecast for next year|Enovis Corp (ENOV) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year ESTA|Expected earnings per share growth for next year iLet Bionic Pancreas BBNX|Earnings growth forecast for next year IRMD (IRADIMED CORPORATION)|Earnings growth forecast for next year embecta.com EMBC|TNDM - Net earnings per share growth forecast for next year|AXGN: Net earnings per share growth forecast for next year|SIBN (SI-BONE Corp) - Expected earnings per share growth for next year|Orthofix Corp - Expected earnings per share trend next year|BVS (Bioventus Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year OrthoPediatrics Inc. KIDS|Net earnings per share growth forecast for next year Treace Medical Concepts, Inc. (TMCI)|Blade Air Mobility (SRTA) - Net earnings per one share growth forecast for next year|Carlsmed Corp - Expected earnings per share growth for next year|Earnings growth forecast for next year RxSight Ophthalmic RXST|ClearPoint - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year stereotaxis.com STXS|Neuronetics (STIM) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year SGHT (Sight Sciences Inc.)|Net earnings per share growth forecast for next year Orchestra BioMed, Inc.|Expected earnings per share growth for next year Anika (ANIK)|Earnings growth forecast for next year NSPR|ZJYL - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Vivani Medical VANI|XTNT: Projected earnings per share growth rate for next year|NMTC: Expected earnings per share growth for next year|Modular Medical - Projected earnings per share increase next year|MYO: Earnings growth forecast for next year|COCH - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Vivos Therapeutics, Inc.|Projected earnings per share growth rate for next year NVNO (enVVeno Medical Corporation)|Expected earnings per share growth for next year SINT (Sintx Technologies)|Projected earnings per share increase next year TNON|Earnings growth forecast for next year LFWD (ReWalk Robotics Ltd.)|Autonomix Medical Inc. (AMIX) - Expected net earnings per share growth next year|INVO Fertility - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Bone Biologics Corp. (BBLG)|Axonics Modulation Technologies (AXNX) - Net earnings per share growth forecast for next year|Biolase Inc. - Expected earnings per share trend next year|DYNT (Dynatronics Corp) - Earnings growth forecast for next year|Earnings growth forecast for next year Paragon 28 Corp|Expected earnings per share growth for next year INVO (INVO Bioscience, Inc.)
